Turning study reports into publications
By Lloyd Czaplewski, Nov 21 2012 08:22AM
Chemical Biology Ventures successfully completed an assignment to review preclinical study reports, to provide a publication strategy and to write the first full paper describing the detailed characterisation of a preclinical compound. The paper was accepted by a leading high impact Journal.
With Company downsizing and staff turnover, effectively managing legacy data from lab books and study reports can be a real problem. Chemical Biology Ventures provided an independent review of the information, a clear path to high value publications that will increase community awareness of the attributes of the compounds and will help engage with key opinion leaders as the programme enters clinical evaluation.
Chemical Biology Ventures News